IMI: Building a science infrastructure for Europe
Interviewee/Contributor
Pierre Meulien
Organisation
Innovative Medicines Initiative
Research Directory
Designing trials for allergy product development
Interviewee/ContributorVincent CharlonOrganisationAnergis SAA strategy for using AI in pharma R&D
Interviewee/ContributorEd CorbettOrganisationNovasecta LtdProducing viral vectors on an industrial scale
Interviewee/ContributorNicole FaustOrganisationCEVEC Pharmaceuticals GmbHDeveloping gene therapies: a manufacturing view
Interviewee/ContributorMadhusudan PeshwaOrganisationGE HealthcareNovartis sets out its vision for pharma R&D
Interviewee/ContributorRobin DavisonOrganisationNew Science Global Healthcare FundLight on the horizon for Swedish biopharma
Interviewee/ContributorSøren TulstrupOrganisationHansa Medical ABGalecto raises €79 million in Series C round
Interviewee/ContributorKaren WagnerOrganisationYsios CapitalRNA therapeutics are now a clinical reality
Interviewee/ContributorTara RaveendranOrganisationShore CapitalGenmab looks ahead to next phase of growth
Interviewee/ContributorJan van de WinkelOrganisationGenmab A/S